FDA is warning prescribers about dental problems connected to buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain. Some dental problems reported in patients include:
- Tooth decay,
- Development of cavities,
- Infections, and
- Erosion in teeth.
FDA noted they are taking several measures to protect the public health, including requiring that a new warning about the risk of dental problems be added to the prescribing information and the patient Medication Guide for all buprenorphine-containing medicines that are dissolved in the mouth.